CDKN2A and neoplasm: Thus, it is possible that in the context of certain tumor types such as those studied here, the decreased expression of SASP factors observed upon p16 knockdown or in CDKN2A-low patients may contribute to abrogation of senescence surveillance by immune cells [48, 108], thereby promoting tumorigenesis.